Decreased expression of SLC 39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer
Main Authors: | Xu, Xiao-Ming, Wang, Cheng-Gong, Zhu, Yu-Di, Chen, Wei-Hua, Shao, Si-Liang, Jiang, Fu-Neng, Liao, Qian-De |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948725/ |
Similar Items
-
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
by: Tuschl, Karin, et al.
Published: (2016) -
The Zinc Transporter SLC39A14/ZIP14 Controls G-Protein Coupled Receptor-Mediated Signaling Required for Systemic Growth
by: Hojyo, Shintaro, et al.
Published: (2011) -
Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy
by: Zeng, X, et al.
Published: (2014) -
SLC7A14 linked to autosomal recessive retinitis pigmentosa
by: Jin, Zi-Bing, et al.
Published: (2014) -
UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
by: Delores J. Grant, et al.
Published: (2017-07-01)